Loading clinical trials...
Loading clinical trials...
To investigate the diagnostic value of ultralow-dose computed tomography in the detection of pulmonary nodules and lung parenchym alterations (e.g. emphysema) compared to standard-dose-CT.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cantonal Hospital of St. Gallen
NCT02796937 · Pulmonary Emphysema in Alpha-1 Antitrypsin Deficiency
NCT01983241 · Pulmonary Emphysema in Alpha-1 PI Deficiency
NCT02556697 · Pulmonary Disease, Pulmonary Emphysema
NCT00683722 · Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema, and more
NCT02719184 · Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema
Klinik für Radiologie und Nuklearmedizin
Sankt Gallen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions